Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Paulo C. Cotrim"'
Autor:
Marcela M. Satow, Edite H. Yamashiro-Kanashiro, Mussya C. Rocha, Luiza K. Oyafuso, Rita C. Soler, Paulo C. Cotrim, Jose Angelo L. Lindoso
Publikováno v:
Revista do Instituto de Medicina Tropical de São Paulo, Vol 55, Iss 6, Pp 393-399 (2013)
SUMMARY This study evaluated the applicability of kDNA-PCR as a prospective routine diagnosis method for American tegumentary leishmaniasis (ATL) in patients from the Instituto de Infectologia Emílio Ribas (IIER), a reference center for infectious d
Externí odkaz:
https://doaj.org/article/3e4d6edd2f9c40f39ee4fac52ef7bf6d
Autor:
José Franco da Silveira, Gláucia S. Paranhos, Paulo C. Cotrim, Renato A. Mortara, Mário E. Camargo, Anis Rassi, Jamiro Wanderley, Ricardo Corral, Hector L. Freilij, Saul Grinstein, Win Degrave
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 85, Iss 4, Pp 507-511 (1990)
Externí odkaz:
https://doaj.org/article/f6e3da55eeba44bb8778a9a00e173570
Autor:
Bianca A. Ferreira, Thaynan F. C. Martins, Elizabeth M. Coser, Viviane da L. Oliveira, Edite H. Yamashiro-Kanashiro, Mussya C. Rocha, Marcelo M. Pinto, Paulo C. Cotrim, Adriano C. Coelho
Publikováno v:
Parasitology Research. 121:2683-2695
Autor:
Juliana Q Reimão, Jordana C Oliveira, Cristiana T Trinconi, Paulo C Cotrim, Adriano C Coelho, Silvia R B Uliana
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 9, Iss 2, p e0003556 (2015)
The only oral drug available for the treatment of leishmaniasis is miltefosine, described and approved for visceral leishmaniasis in India. Miltefosine is under evaluation for the treatment of cutaneous leishmaniasis in the Americas although its effi
Externí odkaz:
https://doaj.org/article/fadedb336b324e0bb5c88a70efab4537
Publikováno v:
The Journal of biological chemistry. 274(53)
We tested a general method for the identification of drug resistance loci in the trypanosomatid protozoan parasite Leishmania major. Genomic libraries in a multicopy episomal cosmid vector were transfected into susceptible parasites, and drug selecti